Form 4: USANA Health Sciences Executive David Mulham Sells Shares

David Mulham, Chief Sales Officer of USANA Health Sciences, sold 4,311 shares of common stock on February 29, 2024.

Summary

• On February 29, 2024, David Mulham, the Chief Sales Officer of USANA Health Sciences, sold 4,311 shares of the company's common stock.
• The sale was executed at a weighted average price of $47.755 per share, with individual transaction prices ranging from $47.63 to $47.89.
• Following the transaction, Mulham directly owns 7,825 shares of USANA Health Sciences.
• The transaction was reported on March 4, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by an officer. It doesn't inherently convey positive or negative sentiment, but the market may interpret the sale based on their own analysis.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The sale of shares by a company officer may influence investor sentiment.

Key Dates